CION Ameerpet
Diagnosis & Staging · Reviewed by CION Oncologists · NABH Accredited
Your Cervical Cancer Pathology Report — Read Line by Line
A histopathology report is written for one oncologist to hand to another, which is why it can be almost unreadable to the person it is about. Yet it is the single most important document in your file: everything downstream depends on it — whether the disease is invasive, what type of cell it started in, how deep it goes, whether it has reached lymphatic channels, and whether the tissue removed carried a clear edge. This page walks through the report section by section, explains what each line is measuring and why, and flags the findings that genuinely change what happens next. It is a translation, not a diagnosis.
- Type, grade, depth, LVSI, margins — the five lines that carry most of the weight
- Millimetres matter — depth of invasion is measured to a tenth of a millimetre because stage turns on it
- p16 and Ki-67 are markers, not extra cancers — stains that help the pathologist be certain
- Slides can be reviewed — a second pathologist reading the same blocks is a normal, expected step
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What the Report Is Actually Deciding
Before the individual lines make sense, it helps to know what the pathologist has been asked to settle. A cervical histopathology report exists to answer four questions in order, and the answers are what your treating team will build a plan on.
- Is this cancer at all? — the difference between a high-grade precancerous lesion confined to the surface layer and an invasive carcinoma that has broken through the basement membrane is the difference between an outpatient procedure and a cancer treatment plan.
- What kind of cancer is it? — squamous, glandular, mixed or one of the rarer subtypes. The subtype influences how the disease behaves and which treatments are expected to work.
- How far has it gone in this piece of tissue? — depth of invasion, horizontal spread, involvement of lymphatic and blood vessel spaces, and whether it reaches the cut edge.
- Is anything left behind? — margin status on an excision specimen tells the surgeon whether the whole abnormality came out.
Everything else on the page — block numbers, stain results, synoptic checklists — exists to support those four answers. The report does not give you a stage on its own. Stage comes from combining the pathology with imaging and examination, which is why a report can be complete while the stage is still being worked out. Our guide to cervical biopsy types and what the results mean covers how the tissue in front of the pathologist was obtained in the first place, and the cervical cancer overview sets the whole pathway out.
Did You Know? The way cervical precancer is named on reports was deliberately simplified. The Lower Anogenital Squamous Terminology (LAST) project, run jointly by the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology, replaced the old three-tier CIN 1 / CIN 2 / CIN 3 scheme with a two-tier system — low-grade and high-grade squamous intraepithelial lesion — because the three-tier version was reported inconsistently between pathologists. Many Indian laboratories now print both, which is why your report may carry a CIN grade and an SIL grade side by side. Source: CAP & ASCCP, Lower Anogenital Squamous Terminology Standardization Project.
The Sections of a Cervical Pathology Report
Different laboratories lay the page out differently, but the same content appears in nearly every report. Find these headings and you have found everything that matters.
Check first
Identifiers and specimen
Your name, age, hospital number, the date the tissue was taken and what was sent — punch biopsy, endocervical curettings, LEEP, cone or hysterectomy. Read this section carefully: a mismatch here is the one error that makes the rest of the report meaningless, and it is worth thirty seconds of your time.
Gross
Macroscopic description
What the specimen looked like to the naked eye before it was cut — size in centimetres, appearance, how it was inked and orientated. Inking is how the laboratory keeps track of which surface was the surgical edge, so that margins can be reported side by side.
The diagnosis
Microscopic description & impression
The pathologist’s reading of the slides and then the bottom line, usually a single sentence in the impression or conclusion. If you read only one part of the report, read this one — but do not read it without the measurements that follow.
Subtype
Histological type
Most commonly squamous cell carcinoma, next most commonly adenocarcinoma, then adenosquamous and rarer subtypes such as small cell neuroendocrine and clear cell tumours. The subtype changes expected behaviour and sometimes the whole treatment approach.
Numbers
Measurements
Depth of stromal invasion and horizontal extent, both in millimetres. These two figures separate microinvasive disease from frankly invasive disease and therefore decide whether a fertility-sparing operation can even be considered.
Stains
Immunohistochemistry
Additional stains applied to the same tissue. p16 is used as a surrogate for high-risk HPV activity, Ki-67 shows how many cells are actively dividing, and markers such as p40 or CK7 help separate squamous from glandular lesions when the appearance alone is ambiguous.
Edges
Margin status
Reported separately for the ectocervical (outer), endocervical (canal) and deep or radial margins. “Free of tumour” is what you want to see; a distance in millimetres from the nearest tumour to the edge is often given as well.
If applicable
Lymph nodes and parametrium
Only present on surgical specimens. The number of nodes retrieved and the number containing tumour are stated for each station. What positive nodes mean is set out separately.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A Report Is Not a Plan
Pathology tells you what the cells are. A tumour board tells you what to do about them. Every confirmed cervical cancer at CION is discussed by surgical, radiation and medical oncology together before treatment is proposed.
The Five Findings That Change What Happens Next
Most of a report is descriptive. These five entries are the ones your oncologist will look for first, because each one can move the plan.
1. Histological type
Squamous cell carcinoma arises from the flat cells covering the outer cervix and accounts for the majority of cases. Adenocarcinoma arises from the glandular cells lining the canal, is harder to catch on a smear because it sits higher up, and has been increasing as a proportion of cervical cancers. The WHO 2020 classification split cervical adenocarcinoma into HPV-associated and HPV-independent types, and that distinction now appears on many Indian reports because the two behave differently. Rarer subtypes — neuroendocrine tumours in particular — are managed along quite different lines.
2. Grade
Grade describes how closely the cancer cells still resemble the tissue they came from. Well differentiated (grade 1) cells look almost normal; poorly differentiated (grade 3) cells have lost that resemblance and tend to grow faster. Grade is a piece of the picture rather than the picture — in cervical cancer it carries less weight than stage, depth and node status, so a grade 3 report on an early tumour is not the alarming finding it might sound like.
3. Depth of stromal invasion
Measured from the basement membrane down into the supporting tissue, in millimetres and often to one decimal place. This number carries real consequences: FIGO defines its earliest invasive categories by depth, and depth is part of what determines whether a cone or trachelectomy could be sufficient or whether a more extensive operation or radiation is needed. Horizontal extent — how wide the invasive area is — is reported alongside it.
4. Lymphovascular space invasion (LVSI)
LVSI means tumour cells have been seen inside the small lymphatic or blood vessel channels within the specimen. It is not the same as nodal spread — it is a sign that the route is being used. Its presence raises the likelihood that nodes are involved and is one of the intermediate-risk features that, in NCCN guidance, can tip the decision towards adding radiation after surgery.
5. Margin status
On a LEEP or cone specimen, an involved margin means abnormal cells reach the cut edge, so something may remain in the cervix. That usually means a repeat excision or close follow-up rather than an escalation to major treatment. On a hysterectomy specimen, margin status feeds into whether radiation is recommended afterwards.
One thing a pathology report cannot tell you: your stage. Stage in cervical cancer is assigned under the FIGO system by combining pathology with examination and imaging — see how FIGO staging is decided. If the report says “invasive squamous cell carcinoma” and nothing about stage, nothing has been left out; the staging work-up is simply a separate step.
Report Phrasebook — What the Wording Means
These are the phrases patients most often bring to a consultation. The right-hand column is a translation, not an interpretation of your particular case.
| What the report says | What it means | Why it matters |
|---|---|---|
| HSIL / CIN 2–3 | High-grade precancerous change, still confined to the surface layer | Not cancer. Usually treated completely with a single outpatient excision |
| Invasive squamous cell carcinoma | Cancer that has broken through the basement membrane into deeper tissue | Confirms a cancer diagnosis; triggers the staging work-up |
| Depth of invasion 2.8 mm | How far below the surface the tumour reaches | Feeds directly into the FIGO stage and into surgical options |
| LVSI present / absent | Tumour seen, or not seen, inside lymphatic or vascular channels | An intermediate-risk feature; may add radiation after surgery |
| Margins free of tumour | No abnormal cells reach the cut edge of the specimen | Suggests the abnormality was removed completely |
| p16 block positive | Strong, continuous staining consistent with high-risk HPV activity | Supports the diagnosis and helps classify the subtype |
| Ki-67 index high | A large proportion of cells are actively dividing | Used alongside p16 to distinguish reactive change from true precancer |
| 0/14 nodes involved | Fourteen nodes were examined; none contained cancer | Node-negative disease — a favourable finding on a surgical specimen |
Once the report and the staging scans are both in, the discussion moves to what is actually done about it — set out on our cervical cancer treatment in Hyderabad page.
When a Second Pathologist Should Look at the Slides
Asking for a review is not a criticism of the first laboratory. Slide review is a routine part of cancer care and is built into most tumour board pathways. There are four situations where it changes things often enough to be worth the days it costs.
The report and the clinical picture do not match
A tiny lesion on colposcopy with an aggressive-sounding report, or a large visible tumour reported as precancer only, is worth a second reading before anything irreversible is planned. Mismatch is the single strongest reason to review.
A rare subtype has been diagnosed
Neuroendocrine, clear cell and some glandular tumours are uncommon enough that confirmation matters, because the treatment path diverges sharply from the usual one. Immunohistochemistry is often added at this stage rather than repeated from scratch.
The measurements sit on a decision boundary
When depth of invasion or margin distance falls within a fraction of a millimetre of a threshold that decides between two very different operations, a second measurement is reasonable — particularly where fertility preservation is being considered.
You are being asked to consent to major surgery
Before a hysterectomy or a course of chemoradiation, it is entirely reasonable to have the diagnosis confirmed independently. Blocks and slides can be borrowed from the original laboratory and returned. Our guide on when a cervical cancer second opinion is worth it explains how to request them without offending anyone.
Did You Know? The WHO Classification of Tumours, 5th edition (2020) made a change to cervical adenocarcinoma that is still working its way onto Indian reports: adenocarcinomas are now divided into HPV-associated and HPV-independent types, rather than by architectural pattern alone. The distinction is made largely on p16 staining and morphology, and it matters because HPV-independent tumours are not picked up by HPV-based screening and tend to behave less predictably. If your report names one or the other, that is current practice, not an unusual finding. Source: WHO Classification of Tumours — Female Genital Tumours, 5th edition.
Why Patients Bring Their Reports to CION
The value of a pathology report is entirely in how carefully it is read and how honestly it is explained.
Reports explained line by line
Slide and block review arranged
Tumour board for every confirmed cancer
Immunohistochemistry where it is needed
Second opinions welcomed
7 NABH-accredited Hyderabad locations
Transparent, itemised costs
EMI facility & insurance accepted
4.8 / 5 Google rating
Take The Next Step
You Should Understand Your Own Report
No one should have to decide about surgery or radiation from a document they cannot read. Bring it in and we will go through it with you, whether or not you are treated here.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Your Cervical Pathology Report — Frequently Asked Questions
How long does a cervical biopsy report usually take?
A routine punch biopsy report is generally ready within a few working days of the tissue reaching the laboratory. Larger excision specimens such as a LEEP, cone or hysterectomy take longer, because the tissue has to be inked, sectioned into many blocks and processed so that every margin can be reported separately. If immunohistochemical stains such as p16 or Ki-67 are added, or if the slides are sent for a specialist opinion, add several more days. A delay is far more often a sign of thoroughness than of bad news — a report that needs extra stains is one where the pathologist has decided not to guess.
What does poorly differentiated mean on my cervical cancer report?
It refers to grade — how closely the cancer cells still resemble the normal cervical tissue they came from. Well differentiated (grade 1) cells look almost like the original tissue; poorly differentiated (grade 3) cells have largely lost that resemblance and tend to divide faster. It is genuinely useful information, but in cervical cancer grade carries considerably less weight than stage, depth of invasion and lymph node status. A poorly differentiated grade on a small, early, node-negative tumour is a very different situation from the same grade on advanced disease, so it should always be read alongside the rest of the report rather than on its own.
My report mentions lymphovascular space invasion. Does that mean it has spread?
Not by itself. LVSI means the pathologist has seen tumour cells inside the small lymphatic or blood vessel channels within the tissue sample. It shows that the route out of the cervix is being used, which raises the statistical likelihood that lymph nodes contain disease — but it is not the same as a positive node, and many women with LVSI have completely clear nodes. In practice it is treated as an intermediate-risk feature: within NCCN guidance it is one of the findings that, combined with tumour size and depth of invasion, can tip the decision towards adding radiation after surgery rather than observing.
What happens if the margins on my LEEP or cone biopsy are involved?
An involved margin means abnormal cells extend to the cut edge of the tissue removed, so some may still be present in the cervix. For a precancerous lesion this usually means either a repeat excision or close follow-up with colposcopy and HPV testing, depending on which margin is involved, your age and whether you want to preserve fertility — an endocervical margin is generally taken more seriously than an ectocervical one. For invasive cancer, an involved margin is one of the findings that feeds into whether further surgery or radiation is recommended. It is not, in itself, evidence that the cancer has spread anywhere.
Why does my report mention p16 and Ki-67, and are those separate cancers?
No — they are stains applied to the same tissue, not additional diagnoses. p16 is a protein that accumulates when high-risk HPV is transcriptionally active in a cell, so strong continuous ("block positive") p16 staining supports a diagnosis of HPV-driven precancer or cancer and helps distinguish it from reactive change that can look similar under the microscope. Ki-67 marks cells that are actively dividing, and a high index in the upper layers of the epithelium points the same way. Together they make a borderline diagnosis considerably more reliable. Seeing them on your report means the pathologist was being careful.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It explains the standard sections of a cervical histopathology report; it is not a reading of your own report and cannot replace a consultation. Reporting formats vary between laboratories. Please go through your report with your treating oncologist before making any treatment decision.